Apontis Pharma

We have a high aspiration: to save lives. As a Single Pill Company, we wish to achieve a paradigm shift with our innovative corporate performance and a reorientation in the long-term therapy of chronically-ill patients with cardiovascular diseases. By substituting loose combinations with the same active ingredient-containing Single Pill, we strive to increase the efficiency of the long-term therapy for chronically-ill patients, in order to prevent cardiovascular events. Thanks to the reduced number of tablets, the significantly increased patient compliance to therapy holds considerable medical and economic potential for improved patient care.